Yingtong Lin
Overview
Explore the profile of Yingtong Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
467
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang X, Wu S, Lin Y, Zhang W, Zhang Y, Li X, et al.
J Med Virol
. 2025 Mar;
97(3):e70295.
PMID: 40088087
HIV-1 establishes a stable latent reservoir in host cells such as CD4 T lymphocytes, which cannot be recognized by the immune system. Accurately assessing the active latent reservoir by HIV-1...
2.
Zhou M, Yang T, Yuan M, Li X, Deng J, Wu S, et al.
J Virol
. 2024 Jul;
98(8):e0003524.
PMID: 39082875
Importance: Identifying host factors involved in maintaining human immunodeficiency virus type 1 (HIV-1) latency and understanding their mechanisms prepares the groundwork to discover novel targets for HIV-1 latent infection and...
3.
Huang F, Lin Y, Qiao Y, Yuan Y, Zhong Z, Luo B, et al.
JCI Insight
. 2024 Jul;
9(15).
PMID: 38954484
Upon infection, naive CD8+ T cells differentiate into cytotoxic effector cells to eliminate the pathogen-infected cells. Although many mechanisms underlying this process have been demonstrated, the regulatory role of chromatin...
4.
The efficacy of acupuncture therapies in cervical spondylotic radiculopathy: A network meta-analysis
Lin Y, Zhong S, Huang C, Zhang G, Jiang G
Heliyon
. 2024 Jun;
10(11):e31793.
PMID: 38912448
Objective: To evaluate the efficacy of acupuncture-related therapy in the Bayesian setting by means of a network Meta-analysis. Methods: Relevant clinical randomized controlled trials(RCTs) of acupuncture-related therapy for Cervical Spondylotic...
5.
Lin K, Xia B, Wang X, He X, Zhou M, Lin Y, et al.
J Transl Med
. 2024 Apr;
22(1):349.
PMID: 38610029
Background: Chimeric antigen receptor T (CAR-T) cell therapy, as an emerging anti-tumor treatment, has garnered extensive attention in the study of targeted therapy of multiple tumor-associated antigens in hepatocellular carcinoma...
6.
Chen T, Deng J, Zhang Y, Liu B, Liu R, Zhu Y, et al.
Mol Cancer
. 2024 Mar;
23(1):53.
PMID: 38468291
Background: Chimeric antigen receptor-T (CAR-T) cells therapy is one of the novel immunotherapeutic approaches with significant clinical success. However, their applications are limited because of long preparation time, high cost,...
7.
He X, Zhang X, Wu B, Deng J, Zhang Y, Zhu A, et al.
Nat Immunol
. 2024 Mar;
25(4):622-632.
PMID: 38454157
The development of a vaccine specific to severe acute respiratory syndrome coronavirus 2 Omicron has been hampered due to its low immunogenicity. Here, using reverse mutagenesis, we found that a...
8.
Xia B, Lin K, Wang X, Chen F, Zhou M, Li Y, et al.
Mol Ther Oncolytics
. 2023 Aug;
30:86-102.
PMID: 37593111
T cell lymphoma (TCL) is a highly heterogeneous group of diseases with a poor prognosis and low 5-year overall survival rate. The current therapeutic regimens have relatively low efficacy rates....
9.
Zhang X, Wu S, Liu J, Chen R, Zhang Y, Lin Y, et al.
Adv Sci (Weinh)
. 2023 Aug;
10(27):e2301034.
PMID: 37526323
Because of the rapid mutation and high airborne transmission of SARS-CoV-2, a universal vaccine preventing the infection in the upper respiratory tract is particularly urgent. Here, a mosaic receptor-binding domain...
10.
Zhang H, Wang Y, Lin Y, Chu W, Luo Z, Zhao M, et al.
Anal Bioanal Chem
. 2022 Dec;
415(5):867-874.
PMID: 36564526
Ochratoxin A (OTA) poses severe risks to the environment and human health, making the development of an accurate and sensitive analytical method for OTA detection essential. In this study, a...